{"url_path":"/sec/advb/10-q/2026/item-2","section_key":"item-2","section_title":"Item 2 Unregistered Sales of Equity Securities","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1941029/0001213900-26-057226-index.html","accession_number":"0001213900-26-057226","cik":"0001941029","ticker":"ADVB","issuer_name":"Advanced Biomed Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1941029/0001213900-26-057226-index.html","primary_entity_key":"0001941029","primary_entity_name":"Advanced Biomed Inc."},"word_count":62,"has_tables":true,"body_markdown":"**Item 2. Unregistered Sales of Equity Securities\nand Use of Proceeds**\n\n \n\nOther than as described in\nthe Company’s Current Report on Form 8-K filed with the SEC on February 2, 2026 and February 10, 2026, the Company did not sell\nany equity securities during the quarter ended March 31, 2026 that were not registered under the Securities Act of 1933, as amended."}